воскресенье, 27 ноября 2016 г.

Actelion and J&J Are in Talks About Takeover of Swiss Drugmaker

Actelion and J&J Are in Talks About Takeover of Swiss Drugmaker


Johnson & Johnson is in talks with Actelion Ltd. about a potential takeover of the $19.9 billion Swiss drugmaker, the companies said Friday, as the U.S. health-care giant works to expand its pharmaceutical lineup. Actelion and J&J confirmed the approach in separate statements Friday, saying it's not certain that a deal will happen.



from Biotech News